September 7, 2021, Palo Alto, California – I Peace, Inc. (CEO: Koji Tanabe), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of induced pluripotent stem cells (iPSCs) expands its personalized iPSC banking service. I Peace launched its clinical-grade personalized iPSC banking service in 2020 in Japan and has already banked several individuals’ iPSCs. The company will collaborate with I’rom Group Co., Ltd. (Japan) to make the service available for clients at every corner of the country. Using this as proof of concept, I Peace plans to launch the iPSC banking service in the U.S. as the next phase of its business expansion. [Read more…]
BEIJING and SHANGHAI and BOSTON, Aug. 31, 2021 — Jacobio Pharmaceuticals (“Jacobio”, 1167.HK) announced a strategic investment in the US-based biotech company Hebecell on August 31. Jacobio will collaborate with Hebecell to develop the next-generation natural killer cell therapy based on induced pluripotent stem cells (iPSC-NK).
Once the deal is completed, Jacobio chairman and CEO Dr. Yinxiang Wang will be appointed as Chairman of Hebecell. [Read more…]
FamiCord Group is investing in a stem cell bank owned by Smart Cells Holdings Limited, UK, acquiring 84.2% of shares.
After the transaction, FamiCord Group will store 610,000 samples belonging to over 450,000 families.
WARSAW, Poland, Aug. 31, 2021 — Polski Bank Komórek Macierzystych S.A. (PBKM), which leads the international FamiCord Group, Europe’s largest stem cell bank, signed a transaction agreement with shareholders of Smart Cells Holdings Limited, based in London UK. [Read more…]
HealthBanks’ Cord Blood Banking Plans Start at $19.99/Month with Lowest Price Guarantee.
IRVINE, CALIFORNIA, USA, August 10, 2021 — HealthBanks Biotech, Inc. (“HealthBanks” or the “Company”), a premium U.S. stem cell and immune cell bank headquartered in Irvine, CA, today announces the launch of its newest cord blood banking membership plans and prices. [Read more…]